These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 14142372)

  • 21. [PORPHYRINURIA IN MENTAL PATIENTS TREATED WITH ATARAXIC DRUGS].
    ANGUIANO G; CASTELLANOS G; BRIONESMDE J; SANCHEZ LF
    Bol Inst Estud Med Biol Univ Nac Auton Mex; 1965 Apr; 23():19-31. PubMed ID: 14326445
    [No Abstract]   [Full Text] [Related]  

  • 22. A further note on the mechanism of the antidotal action of sodium succinate in the mescaline psychosis.
    STEVENSON I; MOKRASCH LC
    Am J Psychiatry; 1958 May; 114(11):1038-9. PubMed ID: 13533639
    [No Abstract]   [Full Text] [Related]  

  • 23. GABA, gamma-hydroxybutyric acid, and neurological disease.
    Wong CG; Bottiglieri T; Snead OC
    Ann Neurol; 2003; 54 Suppl 6():S3-12. PubMed ID: 12891648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dinitrile succinate in various mental disorders].
    MENICHETTI E; MORETTI E
    Riv Patol Nerv Ment; 1951; 72(3):611-3. PubMed ID: 14921756
    [No Abstract]   [Full Text] [Related]  

  • 25. [Basal metabolism in mental patients. Note II].
    SALVATORE M
    Rass Studi Psichiatr; 1959; 48():729-40. PubMed ID: 14441129
    [No Abstract]   [Full Text] [Related]  

  • 26. Protection by GABA and succinic semialdehyde of seed germination and some enzymatic activities against high concentration of hydroxylamine.
    Cañadas S; González MP; Ventura ME
    Rev Esp Fisiol; 1976 Jun; 32(2):91-4. PubMed ID: 935625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of succinic dinitrile in mental diseases].
    MILLI N; PARIGI S
    Riv Sper Freniatr Med Leg Alien Ment; 1951 Dec; 75(4):543-9. PubMed ID: 14930681
    [No Abstract]   [Full Text] [Related]  

  • 28. Catabolism of GABA, succinic semialdehyde or gamma-hydroxybutyrate through the GABA shunt impair mitochondrial substrate-level phosphorylation.
    Ravasz D; Kacso G; Fodor V; Horvath K; Adam-Vizi V; Chinopoulos C
    Neurochem Int; 2017 Oct; 109():41-53. PubMed ID: 28300620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Succinic semialdehyde reductase Gox1801 from Gluconobacter oxydans in comparison to other succinic semialdehyde-reducing enzymes.
    Meyer M; Schweiger P; Deppenmeier U
    Appl Microbiol Biotechnol; 2015 May; 99(9):3929-39. PubMed ID: 25425279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency.
    Gropman A
    Ann Neurol; 2003; 54 Suppl 6():S66-72. PubMed ID: 12891656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Certain biological modifications in mental patients treated with aminazine; preliminary communication].
    LANDO LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1956; 56(2):180-6. PubMed ID: 13338828
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevocational planning and work conditioning for seriously handicapped ex-mental patients: a preliminary report.
    GROB S
    Ment Hyg; 1963 Apr; 47():249-60. PubMed ID: 13950614
    [No Abstract]   [Full Text] [Related]  

  • 33. [Basal metabolism in mental patients. Advisability of the investigation of metabolic rates in narcosis. Note I].
    SALVATORE M
    Rass Studi Psichiatr; 1959; 48():721-8. PubMed ID: 14441128
    [No Abstract]   [Full Text] [Related]  

  • 34. Note on the gastric peristaltic rate observed radiologically in a group of mental patients.
    JUNGMANN H; VENNING P
    Psychosom Med; 1954; 16(6):502-4. PubMed ID: 13215699
    [No Abstract]   [Full Text] [Related]  

  • 35. SODIUM ANTIMONY DIMERCAPTO-SUCCINATE VERSUS TARTAR EMETIC IN THE TREATMENT OF BILHARZIASIS BY VARIOUS SPACED DOSAGE SCHEMES IN EGYPT, U.A.R.
    ABDALLAH A; SAIF M
    J Egypt Med Assoc; 1964; 47():427-38. PubMed ID: 14263409
    [No Abstract]   [Full Text] [Related]  

  • 36. Succinic semialdehyde dehydrogenase deficiency: GABAB receptor-mediated function.
    Buzzi A; Wu Y; Frantseva MV; Perez Velazquez JL; Cortez MA; Liu CC; Shen LQ; Gibson KM; Snead OC
    Brain Res; 2006 May; 1090(1):15-22. PubMed ID: 16647690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [ON THE USE OF GAMMA-OH IN SURGERY].
    COBELLIS F; NAPPI F; RENDA G
    Rass Int Clin Ter; 1964 Oct; 44():1120-4. PubMed ID: 14240226
    [No Abstract]   [Full Text] [Related]  

  • 38. A PRELIMINARY REPORT OF A RESEARCH CONCERNING THE ATTITUDE OF THE FAMILIES OF HOSPITALIZED MENTAL PATIENTS.
    ALIVISATOS G; LYKETSOS G
    Int J Soc Psychiatry; 1964; 10():37-44. PubMed ID: 14112213
    [No Abstract]   [Full Text] [Related]  

  • 39. [OUR EXPERIENCE IN THE USE OF GAMMA OH IN CLINICAL ANESTHESIA (OBSERVATIONS ON 250 CASES)].
    VALENTI F
    Gazz Int Med Chir; 1964 Dec; 68():2185-95. PubMed ID: 14246422
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic effectiveness of hematoporphyrin-dinitrile succinate-vitamin B12].
    MASSIGNAN L
    Minerva Med; 1956 May; 47(35):1337-9. PubMed ID: 13334104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.